UPDATE 1-Fresenius snaps up Akorn, Merck KGaA's biosimilars in separate deals By: Reuters: Company News April 24, 2017 at 18:30 PM EDT * Akorn deal backed by target's management, key shareholder (Adds Fresenius chief quotes, deal details, background) Read More >> Related Stocks: Akorn Inc Merck & Co